Company news
Spruce Biosciences, Inc. news in 2023
Spruce Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 12, 2023
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 17, 2023
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 13, 2023
Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
June 11, 2023
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 24, 2023
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 14, 2023
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
March 15, 2023
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 8, 2023
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
January 8, 2023
Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan
January 4, 2023